Tekla Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Tekla Capital Management’s Portfolio CERE Stock Details CERE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.61M	Hold
2023 Q1	$4.3M	Hold
2022 Q4	$5.57M	Hold
2022 Q3	$4.99M	Buy
2022 Q2	$2.33M	Buy
2022 Q1	$2.58M	Buy
2021 Q4	$1.33M	Buy